Historical record - last NADAC publication: 1/18/2024
Product Information
TACLONEX 0.005%-0.064% SUSPENSION is a brand product labeled by LEO Pharma Inc., priced at $20.7168 per GM under NDC 50222050166. Its NADAC has been published 579 times since Dec 18, 2013.
The High Outlier badge above means this manufacturer's average price in the calcipotriene and betamethasone dipropionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5; 50 mg/g; ug/g
Manufacturer
LEO Pharma Inc.NDC
50222050166
Classification
Brand
Dosage Form
SUSPENSION
Route
TOPICAL
Last Updated
1/18/2024
Active Ingredients
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA022185On Market Since
6/1/2008
Pharmacological Classes
Price Statistics
The NADAC for TACLONEX 0.005%-0.064% SUSPENSION has been published 579 times since Dec 18, 2013, and over the history we have for it it has risen 107.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.7168 per GM |
|---|---|
| All-time high | $20.7168 (Jan 15, 2025) |
| All-time low | $9.9822 (Dec 18, 2013) |
| Median price | $16.7111 |
| Average price | $16.1777 |
| Largest weekly change | +12.0% (Jan 13, 2016) |
| Weeks tracked | 579 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACLONEX 0.005%-0.064% SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for TACLONEX 0.005%-0.064% SUSPENSION, manufactured by LEO Pharma Inc., is $20.7168 per GM (NDC 50222050166), effective Jan 15, 2025.
How has the price of TACLONEX 0.005%-0.064% SUSPENSION changed over time?
Over the history we have for it, the NADAC for TACLONEX 0.005%-0.064% SUSPENSION has risen 107.5%. It has been tracked across 579 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for TACLONEX 0.005%-0.064% SUSPENSION?
Since Dec 18, 2013, the NADAC for TACLONEX 0.005%-0.064% SUSPENSION has ranged from a low of $9.9822 (Dec 18, 2013) to a high of $20.7168 (Jan 15, 2025), with a median of $16.7111 per GM.
Are there cheaper alternatives to TACLONEX 0.005%-0.064% SUSPENSION?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION, is $1.2133 per GM — about 94% below TACLONEX 0.005%-0.064% SUSPENSION.
Who manufactures TACLONEX 0.005%-0.064% SUSPENSION?
TACLONEX 0.005%-0.064% SUSPENSION (NDC 50222050166) is labeled by LEO Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification